BioMarin Announces First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. OIG
8. AMAT
9. SPY
10. SNDX

Go back to BioMarin Announces First Quarter 2018 Financial Results

Goldman Sachs Remains Bullish on BioMarin Pharma (BMRN) Following 1Q

April 26, 2018 8:12 AM EDT

Goldman Sachs reiterated a Buy rating and $132.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) following the company's 1Q earnings release. BMRN reported total revenue of $373.4mn, above FactSet consensus of $349mn, driven primarily by the adoption of the new revenue recognition principle for... More

BioMarin Pharma (BMRN) Misses Q1 EPS by 8c

April 25, 2018 4:06 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $373.4 million versus the consensus estimate of $348.57 million.

For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.

... More